Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jerry S Lanchbury. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jerry S Lanchbury har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:MYGN / Myriad Genetics, Inc. | Chief Scientific Officer | 264 324 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jerry S Lanchbury. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp MYGN / Myriad Genetics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i MYGN / Myriad Genetics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i MYGN / Myriad Genetics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jerry S Lanchbury som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
F - Taxes | −6 470 | 264 324 | −2,39 | 30,88 | −199 794 | 8 162 325 | |
| 2021-10-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
F - Taxes | −4 341 | 270 794 | −1,58 | 30,88 | −134 050 | 8 362 119 | |
| 2021-09-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
F - Taxes | −3 633 | 275 135 | −1,30 | 33,31 | −121 015 | 9 164 747 | |
| 2021-09-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
F - Taxes | −9 747 | 278 768 | −3,38 | 33,31 | −324 673 | 9 285 762 | |
| 2021-09-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −200 | 288 515 | −0,07 | 35,06 | −7 012 | 10 115 336 |
| 2021-09-23 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 58 398 | 288 715 | 25,36 | ||||
| 2021-08-26 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
F - Taxes | −2 233 | 230 317 | −0,96 | 34,81 | −77 731 | 8 017 335 | |
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −30 000 | 0 | −100,00 | |||
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −30 000 | 232 550 | −11,43 | 35,57 | −1 067 100 | 8 271 804 |
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 30 000 | 262 550 | 12,90 | 27,07 | 812 100 | 7 107 228 |
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −40 000 | 30 000 | −57,14 | |||
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 70 000 | −12,50 | |||
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −40 000 | 232 550 | −14,68 | 35,07 | −1 402 800 | 8 155 528 |
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 40 000 | 272 550 | 17,20 | 27,07 | 1 082 800 | 7 377 928 |
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −10 000 | 232 550 | −4,12 | 35,57 | −355 700 | 8 271 804 |
| 2021-08-25 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 10 000 | 242 550 | 4,30 | 27,07 | 270 700 | 6 565 828 |
| 2021-08-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −28 225 | 80 000 | −26,08 | |||
| 2021-08-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −28 225 | 232 550 | −10,82 | 35,57 | −1 004 008 | 8 272 176 |
| 2021-08-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 28 225 | 260 775 | 12,14 | 27,07 | 764 051 | 7 059 179 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −11 775 | 108 225 | −9,81 | |||
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −38 225 | 120 000 | −24,16 | |||
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −11 775 | 232 550 | −4,82 | 35,57 | −418 856 | 8 272 176 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 11 775 | 244 325 | 5,06 | 27,07 | 318 749 | 6 613 878 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −38 225 | 232 550 | −14,12 | 35,24 | −1 347 171 | 8 195 806 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 38 225 | 270 775 | 16,44 | 27,07 | 1 034 751 | 7 329 879 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 775 | 158 225 | −1,11 | |||
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 225 | 0 | −100,00 | |||
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −27 830 | 0 | −100,00 | |||
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −4 170 | 0 | −100,00 | |||
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −4 170 | 232 550 | −1,76 | 34,00 | −141 780 | 7 906 700 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 4 170 | 236 720 | 1,79 | 23,98 | 99 997 | 5 676 546 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −27 830 | 232 550 | −10,69 | 34,00 | −946 220 | 7 906 700 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 27 830 | 260 380 | 11,97 | 23,98 | 667 363 | 6 243 912 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −1 775 | 232 550 | −0,76 | 35,07 | −62 249 | 8 155 528 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 1 775 | 234 325 | 0,76 | 27,07 | 48 049 | 6 343 178 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −16 225 | 232 550 | −6,52 | 33,99 | −551 488 | 7 904 374 |
| 2021-08-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 16 225 | 248 775 | 6,98 | 26,49 | 429 800 | 6 590 050 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −40 000 | 16 225 | −71,14 | |||
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 295 | 56 225 | −5,54 | |||
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −40 000 | 232 550 | −14,68 | 33,74 | −1 349 756 | 7 847 144 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 40 000 | 272 550 | 17,20 | 26,49 | 1 059 600 | 7 219 850 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −3 295 | 232 550 | −1,40 | 33,69 | −111 012 | 7 834 819 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 3 295 | 235 845 | 1,42 | 26,49 | 87 285 | 6 247 534 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −13 295 | 59 520 | −18,26 | |||
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −36 705 | 72 815 | −33,51 | |||
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −13 295 | 232 550 | −5,41 | 33,55 | −446 075 | 7 802 541 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 13 295 | 245 845 | 5,72 | 26,49 | 352 185 | 6 512 434 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −36 705 | 232 550 | −13,63 | 33,55 | −1 231 431 | 7 801 913 |
| 2021-07-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 36 705 | 269 255 | 15,78 | 26,49 | 972 315 | 7 132 565 |
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 603 | 109 520 | −4,87 | |||
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −26 705 | 115 123 | −18,83 | |||
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −17 692 | 0 | −100,00 | |||
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −17 692 | 232 550 | −7,07 | 32,47 | −574 459 | 7 550 898 |
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 17 692 | 250 242 | 7,61 | 19,47 | 344 463 | 4 872 212 |
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −5 603 | 232 550 | −2,35 | 32,29 | −180 921 | 7 509 040 |
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 5 603 | 238 153 | 2,41 | 26,49 | 148 423 | 6 308 673 |
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −26 705 | 232 550 | −10,30 | 32,79 | −875 657 | 7 625 314 |
| 2021-07-12 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 26 705 | 259 255 | 11,48 | 26,49 | 707 415 | 6 867 665 |
| 2021-07-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −30 424 | 141 828 | −17,66 | |||
| 2021-07-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 884 | 0 | −100,00 | |||
| 2021-07-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −1 884 | 232 550 | −0,80 | 31,99 | −60 269 | 7 439 274 |
| 2021-07-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 1 884 | 234 434 | 0,81 | 26,49 | 49 907 | 6 210 157 |
| 2021-07-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −30 424 | 232 550 | −11,57 | 32,29 | −982 391 | 7 509 040 |
| 2021-07-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 30 424 | 262 974 | 13,08 | 26,49 | 805 932 | 6 966 181 |
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 973 | 172 252 | −2,25 | |||
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −948 | 17 692 | −5,09 | |||
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 891 | 1 884 | −50,09 | |||
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −948 | 232 550 | −0,41 | 32,49 | −30 804 | 7 556 410 |
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 948 | 233 498 | 0,41 | 19,47 | 18 458 | 4 546 206 |
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −1 891 | 232 550 | −0,81 | 32,23 | −60 950 | 7 495 412 |
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 1 891 | 234 441 | 0,81 | 26,49 | 50 093 | 6 210 342 |
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −3 973 | 232 550 | −1,68 | 32,43 | −128 855 | 7 542 201 |
| 2021-06-30 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 3 973 | 236 523 | 1,71 | 26,49 | 105 245 | 6 265 494 |
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −28 640 | 18 640 | −60,58 | |||
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −21 360 | 47 280 | −31,12 | |||
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −33 372 | 232 550 | −12,55 | 31,61 | −1 055 036 | 7 351 929 |
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −28 640 | 265 922 | −9,72 | 31,97 | −915 621 | 8 501 526 |
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 28 640 | 294 562 | 10,77 | 19,47 | 557 621 | 5 735 122 |
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −21 360 | 265 922 | −7,44 | 32,47 | −693 559 | 8 634 487 |
| 2021-06-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 21 360 | 287 282 | 8,03 | 19,47 | 415 879 | 5 593 381 |
| 2021-05-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −19 360 | 68 640 | −22,00 | |||
| 2021-05-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −19 360 | 265 922 | −6,79 | 31,97 | −618 949 | 8 501 659 |
| 2021-05-05 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 19 360 | 285 282 | 7,28 | 19,47 | 376 939 | 5 554 441 |
| 2021-04-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −40 000 | 88 000 | −31,25 | |||
| 2021-04-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −40 000 | 265 922 | −13,08 | 31,47 | −1 258 800 | 8 368 565 |
| 2021-04-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 40 000 | 305 922 | 15,04 | 19,47 | 778 800 | 5 956 301 |
| 2021-03-26 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 19 347 | 265 922 | 7,85 | ||||
| 2021-02-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −74 445 | 0 | −100,00 | |||
| 2021-02-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −5 555 | 0 | −100,00 | |||
| 2021-02-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −5 555 | 246 575 | −2,20 | 29,71 | −165 056 | 7 326 508 | |
| 2021-02-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 5 555 | 252 130 | 2,25 | 18,00 | 99 990 | 4 538 340 | |
| 2021-02-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −74 445 | 246 575 | −23,19 | 29,71 | −2 211 992 | 7 326 508 | |
| 2021-02-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 74 445 | 321 020 | 30,19 | 18,00 | 1 340 010 | 5 778 360 | |
| 2020-10-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 39 196 | 246 575 | 18,90 | ||||
| 2020-10-01 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 544 | 207 379 | −2,60 | 13,04 | −72 294 | 2 704 222 | |
| 2020-09-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −3 627 | 212 923 | −1,67 | 12,44 | −45 120 | 2 648 762 | |
| 2020-09-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −4 214 | 216 550 | −1,91 | 12,44 | −52 422 | 2 693 882 | |
| 2020-09-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 544 | 220 764 | −2,45 | 12,44 | −68 967 | 2 746 304 | |
| 2020-09-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 32 800 | 226 308 | 16,95 | ||||
| 2020-08-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 10 068 | 193 508 | 5,49 | ||||
| 2019-10-01 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 157 | 183 440 | −2,73 | 28,63 | −147 645 | 5 251 887 | |
| 2019-10-01 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 544 | 188 597 | −2,86 | 28,63 | −158 725 | 5 399 532 | |
| 2019-09-26 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 544 | 194 141 | −2,78 | 29,93 | −165 932 | 5 810 640 | |
| 2019-09-26 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −4 214 | 199 685 | −2,07 | 29,93 | −126 125 | 5 976 572 | |
| 2019-09-26 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 38 000 | 203 899 | 22,91 | ||||
| 2019-08-13 |
|
5 | MYGN |
MYRIAD GENETICS INC
Common Stock |
G - Gift | −150 | 165 899 | −0,09 | ||||
| 2018-10-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 157 | 166 049 | −3,01 | 46,00 | −237 222 | 7 638 254 | |
| 2018-10-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 544 | 171 206 | −3,14 | 46,00 | −255 024 | 7 875 476 | |
| 2018-09-26 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 544 | 176 750 | −3,04 | 46,65 | −258 628 | 8 245 388 | |
| 2018-09-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 50 000 | 182 294 | 37,79 | ||||
| 2018-09-18 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −6 515 | 132 294 | −4,69 | 46,35 | −301 970 | 6 131 827 | |
| 2018-07-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −46 139 | 0 | −100,00 | |||
| 2018-07-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −3 861 | 0 | −100,00 | |||
| 2018-07-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −3 861 | 138 809 | −2,71 | 43,34 | −167 339 | 6 016 093 | |
| 2018-07-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 3 861 | 142 670 | 2,78 | 30,34 | 117 143 | 4 328 608 | |
| 2018-07-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −46 139 | 138 809 | −24,95 | 43,34 | −1 999 701 | 6 016 093 | |
| 2018-07-13 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 46 139 | 184 948 | 33,24 | 30,34 | 1 399 857 | 5 611 322 | |
| 2018-06-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −57 654 | 0 | −100,00 | |||
| 2018-06-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −2 346 | 0 | −100,00 | |||
| 2018-06-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −2 346 | 138 809 | −1,66 | 40,12 | −94 122 | 5 569 017 | |
| 2018-06-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 2 346 | 141 155 | 1,69 | 30,12 | 70 662 | 4 251 589 | |
| 2018-06-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −57 654 | 138 809 | −29,35 | 40,12 | −2 313 078 | 5 569 017 | |
| 2018-06-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 57 654 | 196 463 | 41,53 | 30,12 | 1 736 538 | 5 917 466 | |
| 2017-10-03 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 459 | 138 809 | −3,78 | 36,18 | −197 507 | 5 022 110 | |
| 2017-10-03 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 869 | 144 268 | −3,91 | 36,18 | −212 340 | 5 219 616 | |
| 2017-09-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −6 897 | 150 137 | −4,39 | 33,05 | −227 946 | 4 962 028 | |
| 2017-09-15 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 50 000 | 157 034 | 46,71 | ||||
| 2016-10-03 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −5 459 | 107 034 | −4,85 | 20,58 | −112 346 | 2 202 760 | |
| 2016-09-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | −4 752 | 112 493 | −4,05 | 20,92 | −99 412 | 2 353 354 | |
| 2016-09-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 46 508 | 117 245 | 65,75 | ||||
| 2015-10-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −50 962 | 0 | −100,00 | |||
| 2015-10-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −50 962 | 70 737 | −41,88 | 41,86 | −2 133 269 | 2 961 051 | |
| 2015-10-28 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 50 962 | 121 699 | 72,04 | 22,93 | 1 168 559 | 2 790 558 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 038 | 50 962 | −9,00 | |||
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −7 298 | 0 | −100,00 | |||
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −5 038 | 70 737 | −6,65 | 41,80 | −210 588 | 2 956 807 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 5 038 | 75 775 | 7,12 | 22,93 | 115 521 | 1 737 521 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −7 298 | 70 737 | −9,35 | 41,80 | −305 056 | 2 956 807 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 7 298 | 78 035 | 10,32 | 16,53 | 120 636 | 1 289 919 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −11 491 | 7 298 | −61,16 | |||
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −11 491 | 70 737 | −13,97 | 41,80 | −480 324 | 2 956 807 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 11 491 | 82 228 | 16,24 | 16,53 | 189 946 | 1 359 229 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −940 | 18 789 | −4,76 | |||
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −940 | 70 737 | −1,31 | 41,80 | −39 292 | 2 956 807 | |
| 2015-10-27 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 940 | 71 677 | 1,33 | 16,53 | 15 538 | 1 184 821 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −270 | 19 729 | −1,35 | |||
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −270 | 70 737 | −0,38 | 41,39 | −11 175 | 2 927 804 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 270 | 71 007 | 0,38 | 16,53 | 4 463 | 1 173 746 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
F - Taxes | −6 897 | 70 737 | −8,88 | 41,39 | −285 467 | 2 927 804 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 0 | −100,00 | |||
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −50 000 | 19 999 | −71,43 | |||
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −10 000 | 77 634 | −11,41 | 39,88 | −398 791 | 3 095 974 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 10 000 | 87 634 | 12,88 | 18,06 | 180 600 | 1 582 670 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −50 000 | 77 634 | −39,17 | 39,88 | −1 993 955 | 3 095 974 | |
| 2015-09-17 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 50 000 | 127 634 | 64,40 | 16,53 | 826 500 | 2 109 790 | |
| 2015-08-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
A - Award | 58 754 | 77 634 | 311,20 | ||||
| 2014-11-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 328 | 0 | −100,00 | ||||
| 2014-11-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | −1 | 0 | −100,00 | ||||
| 2014-11-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 1 | 18 880 | 0,01 | 16,53 | 17 | 312 086 | |
| 2014-11-06 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 4 328 | 18 879 | 29,74 | 23,11 | 100 020 | 436 294 | |
| 2014-07-15 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 10 000 | −66,67 | |||
| 2014-07-15 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −20 000 | 14 551 | −57,89 | 39,85 | −797 082 | 579 917 |
| 2014-07-15 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 20 000 | 34 551 | 137,45 | 18,06 | 361 200 | 623 991 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −30 000 | 30 000 | −50,00 | |||
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −54 676 | 0 | −100,00 | |||
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −5 324 | 0 | −100,00 | |||
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −54 676 | 14 551 | −78,98 | 39,65 | −2 167 701 | 576 893 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 54 676 | 69 227 | 375,75 | 13,28 | 726 097 | 919 335 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −5 324 | 14 551 | −26,79 | 39,65 | −211 077 | 576 893 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 5 324 | 19 875 | 36,59 | 13,28 | 70 703 | 263 940 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −30 000 | 14 551 | −67,34 | 39,80 | −1 194 066 | 579 162 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 30 000 | 44 551 | 206,17 | 18,06 | 541 800 | 804 591 |
| 2014-04-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −3 000 | 14 551 | −17,09 | 39,65 | −118 939 | 576 893 |
| 2014-02-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 54 676 | −15,46 | ||||
| 2014-02-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −24 192 | 0 | −100,00 | ||||
| 2014-02-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −24 192 | 17 551 | −57,95 | 34,55 | −835 754 | 606 329 | |
| 2014-02-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 24 192 | 41 743 | 137,84 | 12,17 | 294 417 | 508 012 | |
| 2014-02-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −10 000 | 17 551 | −36,30 | 34,55 | −345 467 | 606 329 | |
| 2014-02-20 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 10 000 | 27 551 | 56,98 | 13,28 | 132 800 | 365 877 | |
| 2013-09-20 |
|
5 | MYGN |
MYRIAD GENETICS INC
Common Stock |
G - Gift | −184 | 17 551 | −1,04 | ||||
| 2013-09-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 176 225 | 176 225 | |||||
| 2013-09-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
A - Award | 3 775 | 3 775 | |||||
| 2012-12-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
| 2012-12-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −20 000 | 17 735 | −53,00 | 27,18 | −543 680 | 482 108 |
| 2012-12-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 20 000 | 37 735 | 112,77 | 8,63 | 172 600 | 325 653 |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 24 192 | −45,26 | ||||
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 24 192 | −45,26 | ||||
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 808 | 0 | −100,00 | ||||
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 196 | 0 | −100,00 | ||||
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −20 000 | 17 735 | −53,00 | 30,59 | −611 860 | 542 567 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −20 000 | 17 735 | −53,00 | 30,59 | −611 860 | 542 567 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 20 000 | 37 735 | 112,77 | 12,17 | 243 400 | 459 235 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −5 808 | 17 735 | −24,67 | 30,59 | −177 684 | 542 567 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 5 808 | 23 543 | 32,75 | 12,17 | 70 683 | 286 518 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 20 000 | 37 735 | 112,77 | 9,04 | 180 800 | 341 124 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | −3 196 | 17 735 | −15,27 | 30,59 | −97 775 | 542 567 | |
| 2012-11-21 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | 3 196 | 20 931 | 18,02 | 8,63 | 27 581 | 180 635 | |
| 2012-11-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 782 | 0 | −100,00 | |||
| 2012-11-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −13 100 | 16 782 | −43,84 | |||
| 2012-11-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −16 782 | 17 735 | −48,62 | 31,00 | −520 259 | 549 803 |
| 2012-11-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 16 782 | 34 517 | 94,63 | 7,82 | 131 235 | 269 923 |
| 2012-11-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −13 100 | 17 735 | −42,48 | 29,68 | −388 815 | 526 384 |
| 2012-11-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 13 100 | 30 835 | 73,87 | 7,82 | 102 442 | 241 130 |
| 2012-10-09 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 900 | 29 882 | −11,54 | |||
| 2012-10-09 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −3 900 | 17 735 | −18,03 | 28,50 | −111 150 | 505 448 |
| 2012-10-09 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 3 900 | 21 635 | 21,99 | 7,82 | 30 498 | 169 186 |
| 2012-10-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 33 782 | −8,16 | |||
| 2012-10-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −3 000 | 17 735 | −14,47 | 28,50 | −85 500 | 505 448 |
| 2012-10-04 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 3 000 | 20 735 | 16,92 | 7,82 | 23 460 | 162 148 |
| 2012-09-19 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −5 000 | 17 735 | −21,99 | 28,00 | −140 000 | 496 580 |
| 2012-09-14 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 160 000 | 160 000 | |||||
| 2012-03-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 464 | 20 000 | −14,76 | |||
| 2012-03-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −3 464 | 22 735 | −13,22 | 25,00 | −86 600 | 568 375 |
| 2012-03-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 3 464 | 26 199 | 15,24 | 9,04 | 31 315 | 236 839 |
| 2012-03-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −26 536 | 23 464 | −53,07 | |||
| 2012-03-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −26 536 | 22 735 | −53,86 | 25,00 | −663 503 | 568 464 |
| 2012-03-16 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 26 536 | 49 271 | 116,72 | 9,04 | 239 885 | 445 410 |
| 2012-03-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 27 830 | 27 830 | |||||
| 2012-03-08 |
|
4 | MYGN |
MYRIAD GENETICS INC
Incentive Stock Option (right to buy) |
A - Award | 4 170 | 4 170 | |||||
| 2012-02-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −21 804 | 20 000 | −52,16 | |||
| 2012-02-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
S - Sale | X | −21 804 | 22 735 | −48,95 | 24,05 | −524 338 | 546 727 |
| 2012-02-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
M - Exercise | X | 21 804 | 44 539 | 95,90 | 8,63 | 188 169 | 384 372 |
| 2012-02-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
D - Sale to Issuer | X | −6 000 | 22 735 | −20,88 | 24,15 | −144 924 | 549 141 |
| 2012-02-02 |
|
4 | MYGN |
MYRIAD GENETICS INC
Common Stock |
G - Gift | −466 | 28 735 | −1,60 |
